TP53 and cancer: The consensus is that TP53 missense mutations are associated with malignant cancer phenotypes.[45] Based on p53‐KO U87 cells, three hot missense mutants (R175H, R273C, and R248Q) and wild‐type p53 (WT) were introduced using site‐directed mutagenesis with the aid of sgRNA sequences (sgMut).